Europace Advance Access originally published online on January 16, 2006
Europace 2006 8(2):89-95; doi:10.1093/europace/euj038
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NOT PACING THE RIGHT VENTRICLE
The role of pacing mode in the development of atrial fibrillation
Department of Cardiology, Division of Clinical Electrophysiology, J.W. Goethe University, Theodor-Stern-Kai 7, 60590 Frankfurt, Germany
Manuscript submitted 11 July 2005. Accepted after revision 9 November 2005.
Corresponding author. Tel: +49 69 6301 83293; fax: +49 69 6301 3813. E-mail address: c.w.israel{at}em.uni-frankfurt.de
| Abstract |
|---|
|
|
|---|
Asynchronous ventricular pacing has been shown to increase the risk of development of atrial fibrillation (AF) because of various mechanisms: retrograde atrioventricular (AV) conduction with increase in atrial pressure causing acute atrial stretch and reverse flow in the pulmonary veins, mitral regurgitation, reduced coronary blood flow, adverse neuroendocrine reactions, etc. Dual-chamber pacing preserves atrioventricular synchrony. However, in randomized multicentre trials comparing VVI(R) with DDD(R) pacing, AF is only slightly less frequent in the dual-chamber mode. This is most likely due to unnecessary ventricular pacing, which is frequent in dual-chamber pacing. At nominal values, dual-chamber devices usually do not permit intrinsic AV conduction but promote delivery of the ventricular stimulus at an inappropriate time in an inappropriate place. Programming of long AV delays facilitates spontaneous AV conduction but usually cannot completely avoid unnecessary ventricular pacing and causes other problems in the dual-chamber mode. Atrial septal lead placement can improve left-sided AV synchrony and promote spontaneous AV conduction. Programming of the AAI(R) mode is superior to the dual-chamber mode but cannot be used if AV conduction is impaired intermittently or permanently. Therefore, dedicated algorithms enhancing spontaneous AV conduction in the dual-chamber mode are desirable for a large proportion of pacemaker patients.
Key Words: Atrial fibrillation, Dual-chamber pacing, Ventricular pacing, Haemodynamics, AV interval
| Introduction |
|---|
|
|
|---|
Atrial fibrillation (AF) is a common complication in patients with permanent pacemaker therapy. Although its incidence is influenced by the presence of structural heart disease, hypertension, congestive heart failure, or AF before pacemaker implantation, the pacing mode may also have a significant influence on the development of AF. This review provides insights into the haemodynamic properties of VVI and DDD pacing modes with regard to their potential to promote the development of AF.
| Haemodynamic consequences of VVI pacing |
|---|
|
|
|---|
Adverse haemodynamic and electrophysiological effects of VVI pacing during sinus rhythm have been well appreciated. Twenty years ago, the pacemaker syndrome was described,1
|
|
While permanent or intermittent atrial contraction against closed AV valves causes atrial/pulmonary vein distension as one trigger of AF, another AF trigger is represented by mitral regurgitation caused by right ventricular pacing,3
Likewise, it has been shown in animal and human studies that ventricular pacing reduces coronary blood flow,8
10
increases tissue norepinephrine levels,10
and deteriorates the relationship between left ventricular output and myocardial oxygen consumption.11
By these mechanisms, VVI pacing may produce ischaemia which may promote the development of AF. Finally, asynchronous ventricular pacing induces electrical and mechanical atrial remodelling, which may facilitate the induction of AF and thrombus formation in the left-atrial appendage.12
,13
| AF in VVI and DDD pacing: randomized and non-randomized data |
|---|
|
|
|---|
In accordance with this picture of how VVI pacing may cause AF, retrospective and non-randomized studies show a yearly AF incidence of 7% with VVI pacing in contrast to 2% in patients with AAI or DDD pacing14
|
|
For instance, in patients with sick sinus syndrome, the MOST trial showed little difference between VVIR and DDDR pacing for various clinical endpoints.32
| Consequences of DDD pacing with nominal AV delay |
|---|
|
|
|---|
To study the haemodynamic consequences of ventricular pacing in the dual-chamber mode, a study using Doppler ultrasound in the pulmonary veins is quite revealing.37
|
|
|
Therefore, instead of delivering atrioventricular activation sequences that mimic physiological behaviour, poorly programmed dual-chamber devices may apply a ventricular stimulus at a time when the left atrium is activated. This is haemodynamically equivalent to VVI pacing with 1:1 retrograde conduction. Due to maintenance of short nominal AV delays, patients with dual-chamber devices received much more unnecessary ventricular pacing than patients with VVI devices in the MOST and DAVID trials.35
| Dual-chamber pacing with long AV delay |
|---|
|
|
|---|
In the light of the disappointing results of dual-chamber pacing and for the reasons just outlined, attempts have been made to avoid unnecessary ventricular pacing in patients without high-degree AV block by programming long AV delays (e.g. 300 ms) and DDI(R) instead of DDD(R) mode. In a study of 177 patients with sick sinus syndrome and normal AV conduction, patients were randomized to AAI(R) and DDD(R) with short AV delay (
150 ms) or long AV delay (300 ms).46
|
Finally, programming of long AV delays in DDD(R) or DDI(R) modes may cause additional problems such as a limitation of the maximum tracking rate, non-re-entrant VA synchrony,49
|
In conclusion, dual-chamber pacing with long AV delay does not seem to avoid unnecessary ventricular pacing sufficiently to be as effective in preventing AF as AAIR pacing in patients with normal AV conduction, and causes new problems.
| Atrial septal pacing in DDD mode |
|---|
|
|
|---|
Apart from the pacing mode, the atrial lead position may determine the risk of AF development. Lead implantation in the right atrial appendage or high lateral right atrium seems to promote electrical desynchronization of the atria,50
|
| Conclusion |
|---|
|
|
|---|
Ventricular pacing in the VVI(R) mode and also in the DDD(R)/DDI(R) modes seems to be associated with the development of AF. In the VVI(R) mode, AF may be triggered by retrograde conduction or simple coincidence of sinus beat and ventricular stimulus and atrial stretch. In the dual-chamber mode, inappropriate timing of ventricular pacing causes inappropriate left-sided AV intervals, in the worst case synchronizing left-atrial contraction with left ventricular activation. Thus, inappropriately programmed dual-chamber devices may cause AV dissociation or VA synchrony similar to VVI pacing with 1:1 retrograde conduction. Unnecessary (right) ventricular pacing, even if it causes only fusion or pseudo-fusion, should therefore be avoided as much as possible, and intrinsic AV conduction should usually be preferred to ventricular pacing. Inappropriate, fast atrial pacing rates (over-reactive sensor, preventive pacing algorithm) can significantly prolong intrinsic AV conduction and should be avoided. Programming of a long AV interval or DDI(R) instead of DDD(R) mode only partially solves this problem. Atrial septal lead position may compensate for IACD and thus promote more physiological left-sided AV intervals; by a low septal atrial lead position also, the intrinsic AV conduction may be improved. In patients with intact AV conduction, the AAI(R) mode is superior to dual-chamber modes and should be the mode of choice whenever possible. However, if AV conduction is impaired intermittently or permanently, other measures have to be sought to minimize unnecessary ventricular pacing.
| References |
|---|
|
|
|---|
[1] Ausubel K and Furman S. The pacemaker syndrome. Ann Intern Med 1985; 103: 4209.[ISI][Medline]
[2] Allessie M, Boyden P, Camm AJ, Kleber AG, Lab MJ, Legato MJ, et al. Pathophysiology and prevention of atrial fibrillation. Circulation 2001; 103: 76977.
[3] Berglund H, Nishioka T, Hackner E, Kim CJ, Luo H, Fontana G, et al. Ventricular pacing: a cause of reversible severe mitral regurgitation. Am Heart J 1996; 131: 10357.[CrossRef][ISI][Medline]
[4] Cannan CR, Higano ST, Holmes DR. Pacemaker induced mitral regurgitation: an alternative form of pacemaker syndrome. Pacing Clin Electrophysiol 1997; 20: 7358.[CrossRef][Medline]
[5] Ishikawa T, Sumita S, Kikuchi M, Satoh S, Terada K, Kuji N, et al. Diastolic mitral regurgitation when the heart rate is normalised by ventricular pacing. Eur J Cardiac Pacing Electrophysiol 1996; 6: 237.
[6] Maurer G, Torres MA, Corday E, Haendchen RV, Meerbaum S. Two-dimensional echocardiographic contrast assessment of pacing-induced mitral regurgitation: relation to altered regional left ventricular function. J Am Coll Cardiol 1984; 3: 98691.[Abstract]
[7] Cabello JB, Bordes P, Mauri M, Valle M, Quiles JA. Acute and chronic changes in atrial natriuretic factor induced by ventricular pacing: a self controlled clinical trial. Pacing Clin Electrophysiol 1996; 19: 81521.[CrossRef][Medline]
[8] Amitzur G, Manor D, Pressman A, Adam D, Hammerman H, Shofti R, et al. Modulation of the arterial coronary blood flow by asynchronous activation with ventricular pacing. Pacing Clin Electrophysiol 1995; 18: 697710.[CrossRef][Medline]
[9] Kolettis TM, Kremastinos DT, Kyriakides ZS, Tsirakos A, Toutouzas PK. Effects of atrial, ventricular, and atrioventricular sequential pacing on coronary flow reserve. Pacing Clin Electrophysiol 1995; 18: 162835.[Medline]
[10] Lee MA, Dae MW, Langberg JL, Griffin JC, Chin MC, Finkbeiner WE, et al. Effects of long-term right ventricular apical pacing on left ventricular perfusion, innervation, function and histology. J Am Coll Cardiol 1994; 24: 22532.[Abstract]
[11] Owen CH, Esposito DJ, Davis JW, Glower DD. The effects of ventricular pacing on left ventricular geometry, function, myocardial oxygen consumption, and efficiency of contraction in conscious dogs. Pacing Clin Electrophysiol 1998; 21: 141729.[CrossRef][Medline]
[12] Sparks PB, Mond HG, Vohra JK, Yapanis AG, Grigg LE, Kalman JM. Electrical remodeling of the atrial following loss of atrioventricular synchrony. A long-term study in humans. Circulation 1999; 100: 1894900.
[13] Sparks PB, Mond HG, Vohra JK, Yapanis AG, Grigg LE, Kalman JM. Mechanical remodeling of the atrial following loss of atrioventricular synchrony. A long-term study in humans. Circulation 1999; 100: 171421.
[14] Sutton R and Kenny RA. The natural history of sick sinus syndrome. Pacing Clin Electrophysiol 1986; 9: 11104.[CrossRef][Medline]
[15] Markewitz A, Schad N, Hemmer W, Bernheim C, Ciavolella M, Weinhold C. What is the most appropriate stimulation mode in patients with sinus node dysfunction? Pacing Clin Electrophysiol 1988; 9: 111520.
[16] Ebagosti A, Gueuroun M, Saadjian A, Dolla E, Gabriel M, Levy S, et al. Long-term follow-up of patients treated with VVI pacing and sequential pacing with special reference to VA retrograde conduction. Pacing Clin Electrophysiol 1988; 11: 192934.[CrossRef][Medline]
[17] Langenfeld H, Decoster H, Verherstraeten M, Kochsiek K. Atrial fibrillation and embolic complications in paced patients. Pacing Clin Electrophysiol 1988; 11: 166772.[CrossRef][Medline]
[18] Rosenqvist M, Brandt J, Schüller H. Long-term pacing in sinus node disease. Effects of stimulation mode on cardiovascular morbidity and mortality. Am Heart J 1988; 116: 1622.[CrossRef][ISI][Medline]
[19] Sasaki Y, Shimotori M, Akahane K, et al. Long-term follow-up of patients with sick sinus syndrome: a comparison of clinical aspects among unpaced, ventricular inhibited paced and physiologically paced groups. Pacing Clin Electrophysiol 1988; 11: 157583.[CrossRef][Medline]
[20] Bianconi L, Boccadamo R, Di Florio A, Carpino A, Catalano F, Stella C, et al. Atrial versus ventricular stimulation in sick sinus syndrome. Effect on morbidity and mortality. (Abstract). Pacing Clin Electrophysiol 1989; 12: 1236A.[CrossRef]
[21] Feuer J, Shandling A, Messenger J. Influence of cardiac pacing mode on the long-term development of atrial fibrillation. Am J Cardiol 1989; 54: 13769.
[22] Santini M, Alexidou G, Ansalone G, et al. Relation of prognosis in sick sinus syndrome to age, conduction defect, and modes of permanent cardiac pacing. Am J Cardiol 1990; 65: 72935.[CrossRef][ISI][Medline]
[23] Stangl K, Seitz K, Wirtzfeld A, et al. Differences between atrial single chamber pacing (AAI) and ventricular single chamber pacing (VVI) with respect to prognosis and antiarrhythmic effect in patients with sick sinus syndrome. Pacing Clin Electrophysiol 1988; 11: 20805.
[24] Zanini R, Facchinetti AI, Gallo G, et al. Morbidity and mortality of patients with sinus node disease: comparative effects of atrial and ventricular pacing. Pacing Clin Electrophysiol 1990; 13: 20769.[Medline]
[25] Nürnberg M, Frohner K, Podczeck A, et al. Is VVI pacing more dangerous than AV sequential pacing in patients with sick sinus syndrome? (Abstract). Pacing Clin Electrophysiol 1991; 14: 674.
[26] Hesselson AB, Parsonnet V, Bernstein AD, Bonavita GJ. Deleterious effect of long-term single-chamber ventricular pacing in patients with sick sinus syndrome: the hidden benefits of dual chamber pacing. J Am Coll Cardiol 1992; 19: 15429.[Abstract]
[27] Sgarbossa EB, Pinski SL, Maloney JD, Simmons TW, Wilkoff BL, Castle LW, et al. Chronic atrial fibrillation and stroke in paced patients with sick sinus syndrome. Relevance of clinical characteristics and pacing modalities. Circulation 1993; 88: 104553.
[28] Andersen HR, Nielsen JC, Thomsen PE, Thuesen L, Mortensen PT, Vesterlund T, et al. Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick sinus syndrome. Lancet 1997; 350: 12106.[CrossRef][ISI][Medline]
[29] Wharton JM, Sorrentino RA, Campbell P, et al. Effect on pacing modality on atrial tachyarrhythmia recurrence in the tachycardiabradycardia syndrome: preliminary results of the pacemaker atrial tachycardia trial. (Abstract). Circulation 1998; 98: I-494.
[30] Lamas GA, Orav J, Stambler BS, Ellenbogen KA, Sgarbossa EB, Huang SK, et al. Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. N Engl J Med 1998; 338: 1097104.
[31] Connolly SJ, Kerr CR, Gent M, Roberts RS, Yusuf S, Gillis AM, et al. Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators. N Engl J Med 2000; 342: 138591.
[32] Lamas GA, Lee KA, Sweeney MO, Leon A, Yee R, Marinchak RA, et al. Ventricular pacing or dual-chamber pacing for sinus node dysfunction. N Engl J Med 2002; 346: 185462.
[33] Kerr CR, Connolly SJ, Abdollah H, Roberts RS, Gent M, Yusuf S, et al. Canadian trial of physiologic pacing: effects of physiological pacing during long-term follow-up. Circulation 2004; 109: 35762.
[34] Toff WD, Skene AM, Camm AJ, Skehan JD. A prospective comparison of the clinical benefits of dual chamber versus single chamber ventricular pacing in elderly patients with high-grade ventricular block: The United Kingdom Pacing and Cardiovascular Events (UK-PACE) Trial. 2003; Presented at the 52nd Annual Scientific Sessions of the American College of Cardiology, Chicacgo, March 31.
[35] Wilkoff B. Dual chamber pacing or ventricular backup pacing in patients with an implantable defibrillator. JAMA 2002; 288: 311523.
[36] Sweeney MO, Hellkamp AS, Ellenbogen KA, Greenspon AJ, Freedman RA, Lee KL, et al. Adverse effect of ventricular pacing on heart failure and atrial fibrillation among patients with normal baseline QRS duration in a clinical trial of pacemaker therapy for sinus node dysfunction. Circulation 2003; 107: 293237.
[37] Stierle U, Krüger D, Mitusch R, Potratz J, Taubert G, Sheikhzadeh A. Adverse pacemaker hemodynamics evaluated by pulmonary venous flow monitoring. Pacing Clin Electrophysiol 1995; 18: 202834.[CrossRef][Medline]
[38] Ismer B, von Knorre GH, Voss W, Placke J. Approximation of the individual optimal AV delay using left atrial electrocardiography. Herzschrittm Elektrophysiol 2004; 15:(suppl. 1) I/338.
[39] Camous JP, Raybaud F, dolisi C, Schenowitz A, Varenne A, Baudouy M. Interatrial conduction in patients undergoing AV stimulation: effects of increasing atrial stimulation rate. Pacing Clin Electrophysiol 1993; 16: 20826.[CrossRef][Medline]
[40] Raybaud F, Camous JP, Benoit P, Dolisi C, Baudouy M. Relationship between interatrial conduction times and left atrial dimensions in patients undergoing atrioventricular stimulation. Pacing Clin Electrophysiol 1995; 18: 44750.[CrossRef][Medline]
[41] Chirife R, Ortega DF, Salazar AI. Nonphysiological left heart AV intervals as a result of DDD and AAI physiological pacing. Pacing Clin Electrophysiol 1991; 14: 17526.[CrossRef][Medline]
[42] Bayes de Luna A, Cladellas M, Oter R, Torner P, Guindo J, Marti V, et al. Interatrial conduction block and retrograde activation of the left atrium and paroxysmal supraventricular tachyarrhythmia. Eur Heart J 1988; 9: 11128.
[43] Daubert JC, Pavin D, Jauvert G, Mabo P. Intra- and interatrial conduction delay: implications for cardiac pacing. Pacing Clin Electrophysiol 2004; 27: 50725.[CrossRef][Medline]
[44] Goette A, Honeycutt C, Geller JC, Langberg JJ, Klein HU. Effect of right arial pressure on electrical remodeling during atrial fibrillation in dogs. Herzschr Elektrophysiol 1999; 10: 518.[CrossRef]
[45] Ritter P, Vai F, Pioger G. Comparison between DDD and VVIR pacing modes: importance of atrioventricular delay programming. Implications for study protocols. Eur J Cardiac Pacing Electrophysiol 1994; 4: 349.
[46] Nielssen JC, Kristensen L, Andersen HR, Mortensen PT, Pedersen OL, Pedersen AK. A randomized comparison of atrial and dual-chamber pacing in 177 consecutive patients with sick sinus syndrome: echocardiographic and clinical outcome. J Am Coll Cardiol 2003; 42: 61423.
[47] Sweeney MO, Shea JB, Fox V, Adler S, Nelson L, Mullen TJ, et al. Randomized pilot study of a new atrial-based minimal pacing mode in dual-chamber implantable cardioverter-defibrillators. Heart Rhythm 2004; 1: 1607.[CrossRef][ISI][Medline]
[48] Blanc JJ, De Roy L, Mansourati J, Poezevara Y, Marcon JL, Schoels W, et al. Atrial pacing for prevention of atrial fibrillation. Assessment of simultaneously implemented algorithms. Europace 2004; 6: 3719.
[49] Sweeney MO. Novel cause of spurious mode switching in dual-chamber pacemakers: atrioventricular desynchronization arrhythmia. J Cardiovasc Electrophysiol 2002; 13: 6169.[CrossRef][ISI][Medline]
[50] Becker R, Klinkott R, Bauer A, Senges JC, Schreiner KD, Voss F, et al. Multisite pacing for prevention of atrial tachyarrhythmias: potential mechanisms. J Am Coll Cardiol 2000; 35: 193946.
[51] Gozolits S, Fischer G, Berger T, Hanser F, Abou-Harb M, Tilg B, et al. Global P wave duration on the 65-lead ECG: single-site and dual-site pacing in the structurally normal human atrium. J Cardiovasc Electrophysiol 2002; 13: 12405.[CrossRef][ISI][Medline]
[52] Roithinger FX, Abou-Harb M, Pachinger O, Hintringer F. The effect of the atrial pacing site on the total atrial activation time. Pacing Clin Electrophysiol 2001; 24: 31622.[CrossRef][Medline]
[53] Yu WC, Tsai CF, Hsieh MH, Chen CC, Tai CT, Ding YA, et al. Prevention of the initiation of atrial fibrillation: mechanisms and efficacy of different atrial pacing modes. Pacing Clin Electrophysiol 2000; 23: 3739.[CrossRef][Medline]
[54] Padeletti L, Michelucci A, Pieragnoli P, Colella A, Musilli N. Atrial septal pacing: a new approach to prevent atrial fibrillation. Pacing Clin Electrophysiol 2004; 27: 8504.[CrossRef][Medline]
[55] Bailin SJ, Adler S, Giudici M. Prevention of chronic atrial fibrillation by pacing in the region of Bachmann's bundle: results of a multicenter randomized trial. J Cardiovasc Electrophysiol 2001; 12: 9127.[CrossRef][ISI][Medline]
[56] De Voogt W, De Vusser P, Stockman D, Van den Bos A, Anelli-Monti M, Mairesse G, et al. Atrial fibrillation suppression reduces atrial fibrillation burden on patients with paroxysmal atrial fibrillation and class 1 and 2 pacemaker indicationthe OASES study. (Abstract). Eur Heart J 2003; 24:suppl, 369.
[57] Hettrick DA, Euler DE, Pagel PS, Musley SK, Warman EN, Ziegler PD, et al. Atrial pacing lead location alters the effects of atrioventricular delay on atrial and ventricular hemodynamics. Pacing Clin Electrophysiol 2002; 25: 88896.[CrossRef][Medline]
[58] Hettrick DA, Mittelstadt JR, Kehl F, Kress TT, Tessmer JP, Krolikowski JG, et al. Atrial pacing lead location alters the hemodynamic effects of atrial-ventricular delay in dogs with pacing induced cardiomyopathy. Pacing Clin Electrophysiol 2003; 26: 85361.[CrossRef][Medline]
[59] Barold SS and Israel CW. Prevention of atrial fibrillation by conventional permanent antibradycardia pacemakers. Evaluation of nonrandomized studies. In Israel CW and Barold SS (Eds.). Advances in the Treatment of Atrial Tachyarrhythmia. Pacing, Cardioversion, and Defibrillation 2002; Armonk, NY Futura Publishing Co. Inc pp. 4160.
![]()
CiteULike
Connotea
Del.icio.us What's this?
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||







